Vaccination Services

Respiratory Syncytial Virus (RSV) Vaccination Service — Arexvy (GSK)

Respiratory Syncytial Virus (RSV) is a common virus that primarily spreads during winter and spring, posing a particular threat to infants, older people, and individuals with weakened immune systems. This virus can cause severe respiratory infections, including bronchitis and pneumonia, and even be fatal.

Due to the early symptoms of RSV being similar to those of the common cold, many patients are diagnosed only after their condition has worsened. Therefore, individuals over 60 years old and those with chronic conditions such as diabetes and heart disease, who are considered high-risk, are advised to maintain good personal and environmental hygiene and get vaccinated early to reduce the risk of infection.

HEAL Medical now provides RSV Vaccination Service — Arexvy (GSK), effectively reducing the risk of RSV infection and decreasing the likelihood of complications following infection!

The Threat of RSV

Symptoms of RSV infection may include:

Headache, Fever, Runny nose, Cough, Sore throat, Wheezing, Difficulty breathing

RSV infection can lead to severe illness, and individuals aged 60 and above are more likely to be hospitalized.

Serious complication	Pneumonia
Exacerbation of the following conditions:	Congestive Heart Failure, Chronic Obstructive Pulmonary Disease (COPD), Asthma

High-risk individuals for RSV infection:
While RSV can affect anyone, older adults (especially those with chronic illnesses) are at higher risk of developing severe disease due to RSV infection.

Diabetic patients (aged ≥65 years): 2.4-6.4 times higher risk
Asthmatic patients (aged ≥65 years): 2.3-2.5 times higher risk
Coronary artery disease patients (aged ≥65 years): 3.8-6.5 times higher risk
Chronic obstructive pulmonary disease (COPD) patients (aged ≥65 years): 3.5-13.4 times higher risk
Chronic heart failure patients (aged ≥60 years): 4-7.6 times higher risk

Pros on Arexvy (GSK)

Over 82% effective in preventing lung and lower airway infection from RSV in people aged 60 years and older.*

Over 94% effective in preventing lung and lower airway infection from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure, advanced liver or kidney disease, or any chronic respiratory or pulmonary disease.*

Vaccination

Respiratory Syncytial Virus (RSV) Vaccine — Arexvy (GSK)

Suitable for individual aged 60 and older

Service includes:

Doctor consultation
1 dose of vaccine
Injection fee

The fee for the Arexvy vaccination service is HKD$2,800. Please contact us for more details.

PDF Download

Q&A

RSV is a common virus that primarily infects the respiratory tract. It is a significant cause of lower respiratory tract infections in infants and can also affect the elderly and immunocompromised individuals.

RSV spreads through contact with infected secretions such as mucus and saliva. It can be transmitted through hand contact, droplets from sneezes or coughs, and by touching contaminated surfaces. The virus can survive on surfaces for several hours and infect others when they touch their mouth, nose, or eyes after contact with it.

The peak season for RSV infections typically occurs in the fall, winter, and early spring, although the specific timing may vary by region.

Reference

* Data provided by GSK
RSV - CDC from https://www.cdc.gov/rsv/index.html#:~:text=Respiratory Syncytial Virus (RSV),severe RSV and need hospitalization

Respiratory Syncytial Virus (RSV) Vaccination Service — Arexvy (GSK)

The Threat of RSV

Pros on Arexvy (GSK)

Respiratory Syncytial Virus (RSV) Vaccine — Arexvy (GSK)

Q&A

Reference

Do not miss our blogs,
subscribe to us.

Medical Enquiry?
Contact Us.

Respiratory Syncytial Virus (RSV) Vaccination Service — Arexvy (GSK)

The Threat of RSV

Pros on Arexvy (GSK)

Respiratory Syncytial Virus (RSV) Vaccine — Arexvy (GSK)

Q&A

Reference

Do not miss our blogs, subscribe to us.

Medical Enquiry? Contact Us.

Contact Us.

Sign Up for Newsletters

Do not miss our blogs,
subscribe to us.

Medical Enquiry?
Contact Us.